With a stunning Q2 performance, Molina is officially a comeback story

Last year, Molina was rapidly losing money and leaving ACA exchanges, but stunning second-quarter earnings have sparked a turnaround. (Getty/FroYo_92)

Around this time last year, Molina Healthcare had just ousted its two top executives, cut 1,400 jobs and announced it was pulling out of two state marketplace exchanges following a quarter in which it seemed to be burning money on the boardroom floor.

By the end of 2017, Molina would report a net loss of $512 million with earnings per share dropping by $4.59.

Cut to this year, and the story has shifted dramatically. Molina blew the doors off of Wall Street’s second-quarter expectations, reporting a net income of $202 million, nearly doubling its first-quarter profits. The company reported earnings per share of $3.02 and raised its full-year guidance by $3.00 to $7.15-$7.35 per share.


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

Their success has come from paring down operating and medical costs and raising premiums, particularly in the exchanges. While total revenues for the first half of the year came in $384 million less than the first half of 2017, the company slashed operating costs across the board, including a 12% drop in medical care costs and an 18.6% decline in administrative expenses.

RELATED: Molina reports $512M loss as turnaround effort continues

Affordable Care Act premium increases have been a significant driver. In the first half of this year, per-member per-month premiums shot up 41%. Meanwhile, medical costs declined, leading to a 54.4% medical loss ratio, which could be problematic given the 80% threshold required under the ACA.

CEO Joseph Zubretsky attributed the rebound to better use of utilization controls and “tiering out high-cost providers.”

“This company had inconsistent processes,” he said on last week’s earnings call. “It had, in some cases, poor execution in some of our local health plans and by a rigorous performance management process, leading indicators that identify the number of authorizations that are going in, so that we can head off high acuity inpatient trends that are emerging, all of these are contributing to the very favorable medical care ratios that we're experiencing in the first half.”

RELATED: Ex-Molina Healthcare CFO, the last founding family member at the company, resigns from board

The upswing has prompted the company to consider re-entering the ACA exchanges in Utah and Wisconsin after pulling out last year. The company has filed rates in both states but still has time to make a final decision.

“I’m inclined to say that we would re-enter, but we don't have to make a decision until the end of the summer,” Zubretsky said. “We're going to watch every bit of data emerge on 2018 to make sure we have this right and then we'll make the call at that point.”

But the CEO certainly sounded as though his mind is made up and views the ACA marketplace as a source of long-term growth.

“Our outlook for 2019 Marketplace should be maximize margin, hold onto membership and let's see what happens, so that we can perhaps grow this business more aggressively in 2020,” he said.

Suggested Articles

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

Two lawsuits were filed suing the Trump administration to overturn a new rule that would allow healthcare workers to deny care over religious or conscience…

Policy changes are affecting how investors view the skilled home health market and paving the way for potential strategic acquisitions.